Mankind Pharma Limited (NSE:MANKIND)
Mankind Pharma Statistics
Total Valuation
Mankind Pharma has a market cap or net worth of INR 1.06 trillion. The enterprise value is 1.12 trillion.
Market Cap | 1.06T |
Enterprise Value | 1.12T |
Important Dates
The last earnings date was Thursday, July 31, 2025.
Earnings Date | Jul 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Mankind Pharma has 412.73 million shares outstanding. The number of shares has increased by 1.63% in one year.
Current Share Class | 412.73M |
Shares Outstanding | 412.73M |
Shares Change (YoY) | +1.63% |
Shares Change (QoQ) | +0.04% |
Owned by Insiders (%) | 57.72% |
Owned by Institutions (%) | 19.12% |
Float | 106.03M |
Valuation Ratios
The trailing PE ratio is 55.29 and the forward PE ratio is 47.16. Mankind Pharma's PEG ratio is 2.72.
PE Ratio | 55.29 |
Forward PE | 47.16 |
PS Ratio | 8.20 |
PB Ratio | 7.27 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 2.72 |
Enterprise Valuation
EV / Earnings | 59.25 |
EV / Sales | 8.69 |
EV / EBITDA | 35.87 |
EV / EBIT | 45.26 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.58 |
Debt / EBITDA | 2.73 |
Debt / FCF | n/a |
Interest Coverage | 4.25 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 9.38% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 4.79M |
Profits Per Employee | 701,605 |
Employee Count | 26,978 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Mankind Pharma has paid 4.83 billion in taxes.
Income Tax | 4.83B |
Effective Tax Rate | 20.15% |
Stock Price Statistics
The stock price has increased by +26.54% in the last 52 weeks. The beta is 0.34, so Mankind Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.34 |
52-Week Price Change | +26.54% |
50-Day Moving Average | 2,454.34 |
200-Day Moving Average | 2,518.45 |
Relative Strength Index (RSI) | 54.01 |
Average Volume (20 Days) | 763,029 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mankind Pharma had revenue of INR 129.10 billion and earned 18.93 billion in profits. Earnings per share was 46.42.
Revenue | 129.10B |
Gross Profit | 90.06B |
Operating Income | 24.66B |
Pretax Income | 23.95B |
Net Income | 18.93B |
EBITDA | 31.03B |
EBIT | 24.66B |
Earnings Per Share (EPS) | 46.42 |
Balance Sheet
The company has 25.25 billion in cash and 85.11 billion in debt, giving a net cash position of -59.87 billion or -145.05 per share.
Cash & Cash Equivalents | 25.25B |
Total Debt | 85.11B |
Net Cash | -59.87B |
Net Cash Per Share | -145.05 |
Equity (Book Value) | 145.68B |
Book Value Per Share | 347.39 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 69.76%, with operating and profit margins of 19.10% and 14.66%.
Gross Margin | 69.76% |
Operating Margin | 19.10% |
Pretax Margin | 18.56% |
Profit Margin | 14.66% |
EBITDA Margin | 24.04% |
EBIT Margin | 19.10% |
FCF Margin | n/a |
Dividends & Yields
Mankind Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.63% |
Shareholder Yield | n/a |
Earnings Yield | 1.79% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |